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Objective: There are extremely limited data on minority populations, especially 
Hispanics, describing the clinical epidemiology of acute coronary disease. The aim 
of this study is to examine the incidence rate of acute myocardial infarction (AMI), 
in-hospital case-fatality rate (CFR), and management practices among residents of 
greater San Juan (Puerto Rico) who were hospitalized with an initial AMI.
Methods: Our trained study staff reviewed and independently validated the medical 
records of patients who had been hospitalized with possible AMI at any of the twelve 
hospitals located in greater San Juan during calendar year 2007.
Results: The incidence rate (# per 100,000 population) of 1,415 patients hospitalized 
with AMI increased with advancing age and were significantly higher for older 
patients for men (198) than they were for women (134). The average age of the study 
population was 64 years, and women comprised 45% of the study sample. Evidence-
based cardiac therapies, e.g., aspirin, beta blockers, ACE inhibitors/angiotensin 
receptor blockers, and statins, were used with 60% of the hospitalized patients, and 
women were less likely than men to have received these therapies (59% vs. 65%) or 
to have undergone interventional cardiac procedures (47% vs. 59%) (p<0.05). The 
in-hospital CFR increased with advancing age and were higher for women (8.6%) 
than they were for men (6.0%) (p<0.05).
Conclusion: Efforts are needed to reduce the magnitude of AMI, enhance the use 
of evidence-based cardiac therapies, reduce possible gender disparities, and improve 
the short-term prognoses of Puerto Rican patients hospitalized with an initial AMI. 
[P R Health Sci J 2013;3:138-145]
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Heart disease has been the leading cause of death in the United States since the early 1920s and in Puerto Rico since the late 1940s (1, 2). Coronary Heart Disease 
(CHD) caused approximately 1 out of 6 deaths in the United 
States and 1 out of 10 deaths in Puerto Rico in 2008 (3, 4). 
Comparatively speaking, Puerto Rican Hispanics living in 
the United States have a higher CHD mortality rate (176 per 
100,000 population) than do both Cuban Americans (167 per 
100,000) and Mexican Americans (116 per 100,000) (5).
There has been a consistent decline in the death rate attributed 
to CHD in the United States since the mid- to late-1960s (1, 6, 
7). From 1996 to 2006, the overall decline in CHD mortality in 
the United States was 36%, while it was 24% in Puerto Rico. (8) 
The reasons for the ongoing decline in CHD-related mortality 
are only partially understood, however, and represent the 
contribution of numerous factors, including improvements in 
diagnostic capabilities, early intervention for acute myocardial 
infarction (AMI), and the increasing use of highly effective 
treatments for CHD and its predisposing factors. Despite these 
encouraging declines in CHD death rate, data from several 
sources in the United States and Puerto Rico suggest that the 
prevalence of several important risk factors for CHD (among 
which are obesity, diabetes, and physical inactivity) continue 
to increase (9-16); these disturbing trends may be associated 
with future increases in the incidence rates of acute coronary 
disease.
Despite the magnitude and impact of CHD, there is little 
data (none on patients in Puerto Rico) regarding the incidence 
and case-fatality rates of patients of different races/ethnicities 
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who have been hospitalized because of AMI; in addition, data 
about the therapies used in the management of these patients 
remain limited. The objectives of this observational study were 
to examine, from a community-wide perspective, the overall, 
as well as age- and sex-specific, incidence rate, the in-hospital 
case-fatality rate, and the therapeutic management of initial 
AMI in Puerto Rican patients discharged from 12 hospitals in 
the greater San Juan area, Puerto Rico in 2007. 
Methods
The study sample consisted of residents living in the greater 
San Juan (Puerto Rico) area (2010 census estimate = 858,207 
adults ≥ 18 years old) who, in 2007, were hospitalized for a 
possible AMI at any one of the 12 academic or non-teaching 
medical centers. The greater San Juan area included the 
following 9 municipalities: Bayamón, Canóvanas, Carolina, 
Cataño, Guaynabo, Loíza, Río Grande, San Juan, and Trujillo 
Alto. This area was selected based on the review of data from 
the Puerto Rico Department of  Health (DOH), which collects 
information on the admission of San Juan residents to any of the 
area hospitals and to any of the hospitals in neighboring towns. 
According to the Puerto Rico DOH, virtually all greater San Juan 
residents seek care for their AMIs at participating hospitals; the 
vast majority (~90%) of patients with a primary or secondary 
discharge diagnosis of AMI is hospitalized at 1 of the 6 tertiary 
care/university hospitals. This fact enhances the external 
validity of our findings as well as the comparability with other 
population-based studies (17, 18). Information on all 2007 
hospital discharges in San Juan with International Classification 
of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 
code 410 in the principal and/or secondary diagnosis position 
and related acute and chronic coronary disease ICD-9 rubrics 
(e.g., 412 [old MI], 413 [angina pectoris], 414 [other forms 
of chronic CHD], and 786.5 [chest pain]) was obtained from 
each of the participating hospitals (all of which had emergency 
room capability and served non-institutionalized, non-military 
residents of greater San Juan). The incidence rate was calculated 
utilizing the number of validated cases of AMI in participating 
hospitals and the total number of adults residing in the greater 
San Juan area. 
Once the computerized discharge diagnosis printouts were 
obtained from each of our 12 participating hospitals, the 
appropriate ICD-9-CM codes for CHD were reviewed for 
purposes of selection and case validation. Each participating 
hospital was able to provide us with a patient-specific zip code 
listing that allowed us initially to screen out patients hospitalized 
for suspected acute coronary disease but who lived outside of the 
greater San Juan. Once selected, a list of medical record numbers 
was given to the medical record department personnel at each 
of the participating hospitals. Trained nurse and physician 
abstractors reviewed the medical records of all of the identified 
patients meeting the pre-defined geographic inclusion criteria 
(e.g., residents of greater San Juan).
 Since we were interested in documenting the incidence 
rates of newly diagnosed AMI, we restricted our study sample 
to patients hospitalized with an initial (incident) AMI that 
occurred in 2007. Patients initially hospitalized in one hospital 
and then transferred to another during the same event were 
counted only once. Data were abstracted from the applicable 
emergency medical record of the transferring hospital and 
from the applicable medical record of the receiving hospital. 
The records of any previous hospitalizations for CHD were 
reviewed when available and when the review of the hospital 
chart indicated that the present hospitalization was not the first 
for CHD, regardless of whether the patient was hospitalized in 
different hospitals for separate events. We excluded patients with 
ECG changes indicative of prior MI (old Q-waves on ECG) or 
with a documented history of MI. We excluded patients who 
developed AMI resulting from an interventional or surgical 
procedure. 
In this study, each case was validated using the widely 
accepted diagnostic definition developed by the World Health 
Organization (WHO), which requires that at least 2 of 3 
criteria be present for the confirmation of AMI. This schema 
uses information from the patient’s clinical history that is 
suggestive of AMI, serum enzyme elevations, and serial ECG 
findings of AMI. These criteria have been utilized in a number 
of clinical and epidemiological investigations, e.g., the Worcester 
Heart Attack Study and the World Health Organization 
Multinational Monitoring of Trends and Determinants in 
Cardiovascular Disease (MONICA) Project (17-19). An 
autopsy confirmation of recent onset MI satisfied the study 
inclusion criteria, irrespective of the other diagnostic criteria. 
Patients who developed AMI resulting from an interventional 
procedure or surgery, other than for the treatment of an acute 
coronary event, were excluded from the study. Documentation 
for allergies or contraindications to the receipt of aspirin, beta-
blockers, angiotensin converting enzyme (ACE) inhibitors or 
angiotensin receptor blockers (ARB), and lipid-lowering agents 
were specifically reviewed in each hospital medical record. 
The receipt of evidence-based medicines that have shown 
to lower mortality during an AMI was defined as “beneficial 
secondary prevention cardiac therapy”. Specifically, we 
estimated the percentage of patients who were given aspirin 
within 24 hours of admission and at the time of hospital 
discharge and the percentage of patients who were given beta-
blockers, ACE inhibitors or ARBs, and/or lipid-lowering agents 
at their discharge. 
Data collection
Demographic and clinical data and complete medical 
histories were abstracted from hospital medical records into a 
standardized case-report form by trained nurse and physician 
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abstractors. These data included each patient’s age, sex, 
municipality of residence, coronary risk factors (e.g., diabetes, 
hypertension, smoking), comorbidities (e.g., history of angina, 
stroke, heart failure), physiologic parameters (e.g., heart rate, 
blood pressure, lipid profile, serum creatinine/glucose findings), 
AMI-associated characteristics (e.g., ST-elevation AMI, non-
ST-elevation AMI), use of cardiac medications and secondary 
prevention practices, and survival status at the time of hospital 
discharge. All quality control measures were continuously 
monitored and any identified errors were discussed with each 
reviewer to ensure a high degree of accuracy and observer 
reliability so that documentation errors were minimized.
Data analysis
The age-adjusted (overall and sex-specific) incidence rates 
of initial AMI were calculated in a standard manner using U.S. 
census estimates of the greater San Juan (Puerto Rico) area 
population in 2000 (n = 866,000; 55% women). Means and 
frequency distributions of patient demographic and clinical 
characteristics were calculated in a standard fashion. A given 
patient’s short-term outcome was examined by calculating 
the in-hospital case-fatality rates (CFRs). Since we were 
interested in possible sex-based differences in our principal 
study outcomes, differences in the distribution of demographic 
and clinical characteristics (e.g., comorbid conditions) and 
hospital management practices between men and women were 
examined by using chi-square tests of statistical significance for 
discrete variables and t tests for continuous variables. Logistic 
regression modeling was used to assess crude and age-controlled 
in-hospital case fatality rates. All analyses were performed using 
STATA® version 11.0 (20). The Committee for the Protection 
of Human Subjects at each participating hospital approved 
this study. 
Results
A total of 1,839 patients were hospitalized with independently 
validated AMIs at participating hospitals in the greater San Juan 
area in 2007, of which approximately 65% (1,415) of the patients 
had an initial (de novo) episode. We excluded 417 cases: 415 had 
a history of documented MI and 2 had a history of post-surgical 
MI. The average age of the members of the study population 
was 64 years, 45% were women, and all were residents of greater 
San Juan (Table 1). The overall age-adjusted incidence rate 
(per 100,000 population) of AMI for Puerto Ricans was 163. 
The incidence rate of initial AMI was higher for older patients 
and was significantly higher for men (198) than they were for 
women (134) (Figure 1).
Baseline characteristics
The average hospital stay was 5.5 days. A history of diabetes 
and hypertension was frequently found in the members of this 
Figure 1. Incidence rates (per 100,000) of acute myocardial infarction 
by age and sex: The Puerto Rico heart attack study (Overall incidence 
rate for males: 198 per 100,000 population; for females: 134 per 
100,000 population)
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Table 1. Characteristics of patients with an initial acute myocardial 
infarction
Characteristic Male Female p-value
 (n = 778) (n = 637) 
Demographics   
Age, years (mean +/- SD) 63.2 +/- 13.7 68.6 +/- 13.3 <0.001
Age (%)   
<55 26.1  15.4  <0.001
55-64 28.8  24.5  
65-74 22.8  24.2  
75-84 15.8  23.4  
>85  6.6  12.6  
Body Mass Index > 30 (%)  29.2  30.7  0.64
Medical history (%)   
Angina  3.6   3.6  0.98
Diabetes  40.7  54.0  <0.001
Hypertension  64.7  80.5  <0.001
Stroke   2.5   6.4  <0.005
Heart failure   4.4  10.8  <0.005
Current smoker  22.2  10.2  <0.001
Physiological parameters     
mean (+/- SD), at hospital
presentation
Initial heart rate  81.9 (+/- 20.2) 85.8 (+/- 23.2) 0.99
Systolic blood pressure, 
   mmHg 141.7 (+/- 31.6) 144.8 (+/- 35.8) 0.95
Diastolic blood pressure, 
   mmHg 80.8 (+/- 17.2) 78.4 (+/- 18.4) <0.05
Initial cholesterol, mg/dL 167 (+/- 47.4) 179 (+/- 52.8) 1.00
Initial HDL-cholesterol, 
   mg/dL 36.9 (+/- 18.4) 49.8 (+/- 22.0) 0.001
Initial LDL-cholesterol, 
   mg/dL 96.0 (+/- 57.9) 86.3 (+/- 54.7) 0.001
Creatinine, mg/dL 37.1 (+/- 22.9) 33.3 (+/- 25.0) 0.005
Glucose, mg/dL 118.0 (+/- 107.2) 127.2 (+/- 104.2) 0.94
Hemoglobin, g/dL 14.3 (+/- 7.6) 12.5 (+/- 1.8) <0.0001
Acute Myocardial 
Infarction Characteristics   
ST-segment elevation 35.2 24.4 <0.05
Length of hospital stay 
(mean days) 5.5 (+/- 3.0) 5.5 (+/- 3.7) 0.97
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patient population. Compared to men, women were less likely 
to have smoked cigarettes, were more likely to have experienced 
an initial AMI at an older age, and were more likely to have a 
history of diabetes, hypertension, stroke, heart failure, or a 
combination of any or all of the previous. At the time of hospital 
admission, the women whose case histories were part of the 
study had higher average serum HDL-cholesterol levels than 
did the men, whereas the men presented with higher average 
levels of LDL-cholesterol, creatinine, and hemoglobin than the 
women did. Men were more likely than women to present with 
an ST-segment elevation AMI (Table 1). 
Hospital management practices
At the time of admission for AMI, approximately 4 out of 
every 5 patients were treated with aspirin. At hospital discharge, 
approximately 3 out of every 5 patients were prescribed aspirin 
or ACE inhibitors, whereas only half of the patients were 
prescribed lipid-lowering medications and/or beta-blockers. 
Compared to men, women were significantly less likely both to 
have received aspirin within 24 hours of admission and upon 
being discharged and to have received each of the beneficial 
secondary prevention cardiac therapies and diagnostic/
revascularization procedures (Table 2). Only one third of the 
current smokers received smoking cessation counseling at the 
time of hospital discharge.
In-hospital case-fatality rate
One hundred and two patients died in the hospital after 
developing an AMI. The overall in-hospital CFR after an initial 
AMI was significantly higher for women (8.6%) than it was for 
men (6.0%) (p<0.05). This difference remained significant 
after adjusting for age and other potential confounders such as 
medical history of diabetes, hypertension, stroke, heart failure, 
and smoking. The in-hospital death rate increased significantly 
with age in both men and women (Table 3). 
Discussion
The results of this population-based study provide the latest 
insights into the magnitude and management of and short-term 
death rates associated with AMI among residents of greater San 
Juan and demonstrate sex-based differences in the incidence and 
in-hospital death rates of AMI as well as in its management. 
Incidence rate of initial AMI
The frequency of AMI in Puerto Rican residents has not been 
published prior to this study. We found an overall incidence rate 
of 163 AMI events per every 100,000 individuals residing in the 
greater San Juan area in 2007. Puerto Rican men had significantly 
higher age-adjusted incidence rates of initial AMI than did 
Puerto Rican women, and the men in this sample were more 
likely to have been hospitalized with an initial AMI at a younger 
age than was the case with women. These age- and sex-based 
differences in the incidence rates of AMI are consistent with 
previously published findings (17, 21, 22). Data describing the 
incidence rates of CHD in Hispanics are limited and are based 
on small numbers (23). Indeed, an extremely limited number 
of CHD surveillance systems, including the Worcester Heart 
Attack Study (WHAS), Minnesota Heart Survey (MHS), and 
Olmsted County Study, remain operative in the U.S., and the 
number of Hispanic patients included in these observational 
studies is limited, as the vast majority of the populations studied 
in these community-based coronary disease registries are white 
(24-26). In comparison with other population-based studies, the 
incidence rate of AMI in residents of San Juan, Puerto Rico (163 
per 100,000 population), is slightly lower than the incidence rate 
of initial AMI observed in the Worcester, MA, metropolitan area 
in 2005 (209 per 100,000 population) (24). In the MHS, the 
incidence rate of AMI was 188 per 100,000 population in 1995 
(25), and the incidence rate of hospitalized AMI in Olmsted 
County was 182 per 100,000 population in 1998 (27). 
To the best of our knowledge, this is the first report, from a 
community-wide perspective, describing the incidence rates of 
AMI for the residents of the Caribbean island of Puerto Rico. 
Additional studies in diverse population settings are needed 
to obtain a better understanding of the magnitude of AMI and 
the impact of well-accepted, and more novel, risk factors on the 
development of AMI in men and women of different ages.
Table 2. Hospital treatment practices
Medication (%)*  Male Female p-value
 (n = 778) (n = 637) 
Aspirin within 24 hours of admission 83.3 76.2 <0.05
Aspirin at discharge 66.5 57.8 <0.005
ACE inhibitor/Angiotensin blockers
   (ARB) at discharge 64.8 54.9 0.58
Lipid-lowering agent at discharge 57.3 53.3 0.73
Use of β blocker at discharge 51.2 51.3 0.99
Overall beneficial secondary
   prevention therapies  64.6 58.7 <0.05
Procedure (%)    
Cardiac catheterization  68.2 57.5 <0.001
Percutaneous coronary intervention  51.6 37.6 <0.05
Coronary artery bypass graft 7.1 5.9 0.40
Lifestyle secondary prevention 
measures (%)   
Smoking cessation counseling 27.5 29.2 0.82
*Prescribed medications to patients without known drug contraindications
In examining the management of patients hospitalized with 
AMI (according to the type of AMI), men with either ST-
segment elevation or non−ST-segment elevation AMI were 
more likely to have undergone cardiac catheterization or a 
PCI than were women under the same circumstances. Among 
patients with a non−ST-segment elevation AMI, men were more 
likely than women to have been prescribed aspirin at the time 
of hospital discharge (Figures 2 and 3). 
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Figure 2. Cardiac medications and procedures used in patients hospitalized with ST-Elevation acute myocardial infarction. Legend: ACE= 
Angiotensin Converting Enzyme; ARBs = Angiotensin Receptor Blockers; PCI= Percutaneous Intervention; CABG= Coronary Bypass Artery 
Graft.
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Figure 3. Cardiac medications and procedures used in patients hospitalized with Non ST-Elevation acute myocardial infarction. Legend: ACE= 
Angiotensin Converting Enzyme; ARBs = Angiotensin Receptor Blockers; PCI= Percutaneous Intervention; CABG= Coronary Bypass Artery 
Graft.
Table 3. In-Hospital case-fatality rates (CFR) according to age and 
sex
Males n Crude CFR  Age-specific risk of 
  (%) Dying OR (95% CI)
Age (yrs)   
<55 203 1.5 1.0*
55-64 224 2.2 0.70 (0.18, 2.70)
65-74 177 10.7 0.14 (0.04, 0.45)
75-84 123 11.4 0.13 (0.04, 0.43)
>85 51 11.8 0.12 (0.03, 0.47)
Females   
<55 98 2.0 1.0*
55-64 156 9.6 0.24 (0.06, 0.92)
65-74 154 7.1 0.32 (0.08, 1.30)
75-84 149 15.4 0.14 (0.04, 0.53)
>85 80 5.0 0.44 (0.09, 2.13)
*referent category
Characteristics of patients hospitalized with AMI
The median age of a Puerto Rican resident of greater San 
Juan experiencing a first AMI (65 years) was considerably lower 
than the average age reported in the WHAS (71 years) in 2005 
and the Rochester (MN) Epidemiology Project (69 years) 
during the years of 1979 to 1994 (28, 29). Similar to results 
from the Atherosclerosis Risk in Communities study (30), 
our findings show that the median age of persons having a first 
AMI was almost 5 years higher for women than it was for men. 
On the other hand, our data contrast with the findings noted 
in the INTERHEART study, which showed that an initial AMI 
occurred at relatively younger ages for both women and men 
(65 and 56 years, respectively) (21) who were enrolled in this 
international study. Although a history of diabetes (47%) and 
hypertension (72%) was frequent in our study’s participants, 
higher percentages for both conditions were reported for women 
than they were for men. In agreement with these findings, it 
has been reported that, irrespective of age, women hospitalized 
with AMI were more likely to have a history of hypertension, 
diabetes, heart failure, and stroke than men were (31). In the 
population-based WHAS and in the National Registry of 
Myocardial Infarction (NRMI), approximately three quarters 
and two thirds of the patients hospitalized with AMI had a 
history of hypertension, respectively; the proportion of patients 
with a history of diabetes was identical (28%) in these 2 studies 
(25, 32). In addition, in our study prior histories of heart failure 
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and stroke were noted in a higher percentage of women than 
were noted in men.
The results of the present study suggest that the length of 
hospital stay was similar in Puerto Rican men and women 
hospitalized with AMI and is similar, as well, to that reported 
for patients hospitalized with AMI in 2005 in a large central 
New England metropolitan area (33). Our findings suggest that 
the initial presentation of an AMI occur at a younger age in the 
members of our study sample than is the case in non-Hispanic 
patients residing in the United States. In addition, women present 
with their first AMI at an older age and have more previously 
diagnosed comorbidities than men do. These data suggest that 
this particular, mostly Hispanic, population may have either a 
greater prevalence of or burden from CHD risk factors than do 
whites and that interventions designed to improve the lifestyle 
practices of Hispanics need to be undertaken at an early age to 
prevent, or at least delay, the onset of AMI at a later age. 
Hospital management practices
The prescription of aspirin (both on admission and at the time 
of discharge), ACE inhibitors/ARBs, and beta blockers (discharge 
only) and the incidence of smoking-cessation counseling both 
fell below the levels recommended by the American Heart 
Association and the American College of Cardiology (34). In 
this study, approximately 6 out of every 10 patients received 
the 4 medications examined. This is important, given that our 
sample included patients without known drug contraindications. 
Findings from the WHAS suggest that similar prescribing 
rates were observed after patients with contraindications to 
cardiac medications were excluded (35). In that study, despite 
encouraging increases in the use of multiple evidence-based 
cardiac therapies from 1995 to 2005, slightly fewer than half 
of those patients with AMI were administered all 4 cardiac 
medications during the 2 most recent years under review. Indeed, 
a large percentage of patients (of all ages, both men and women) 
were not treated with all 4 beneficial secondary prevention cardiac 
therapies while being hospitalized for AMI (35).
Older women in our study were the least likely to receive 
beneficial secondary prevention cardiac therapies while being 
hospitalized for AMI. Although being of an advanced age and 
being female have both been associated (by not only the WHAS 
but also the multinational Global Registry of Acute Coronary 
Events) with the underutilization of beneficial secondary 
prevention cardiac therapies in AMI (35, 36), these findings 
are not consistent with a recent report from the MHS that failed 
to observe any gender-based differences in the management of 
patients hospitalized with AMI in the early 2000s (37). 
Data from the Puerto Rico Heart Attack Study suggest a 
differential use of cardiac catheterization and percutaneous 
coronary intervention and indicate that, regardless of the type 
of AMI, women are less likely than men are to receive these 
interventions. In the MHS, women were less likely to be referred 
for coronary angiography than were men in 2001-2002, but 
this was not the case regarding the subsequent use of coronary 
revascularization procedures (37).
Several studies have shown that patients not receiving 
effective cardiac medications after an AMI have missed an 
important opportunity for more secondary prevention (38, 
39). In our study, the reasons for the less-than-optimal use 
of these effective treatment regimens are unknown; the 
recommendations for the management of AMI are similar for 
both subtypes of AMI, although they differ with respect to the 
timing of cardiac catheterization and PCI. We did not collect 
information on the extent of pre-hospital delay from the time 
of onset of acute coronary symptoms to hospital arrival and 
were unable to determine whether differences in the receipt 
of diagnostic and revascularization procedures were related to 
more prolonged delay times in seeking medical care in women 
compared to such times in men. Further, more (and more 
systematic) studies are needed if we are to understand the 
reasons for the aforementioned less-than-optimal proportion 
of AMI patients discharged on effective cardiac medications 
after hospitalization for an initial AMI and if we are to design 
effective educational interventions aimed at increasing the use 
of these treatment modalities in hospitalized patients. 
In-hospital case-fatality rates 
The overall in-hospital CFR of our study (7.3%) is higher 
than the rate reported in the MHS for 2001 (5.4%) (31) and 
lower than that reported in the WHAS for 2005 (9.5%) (25). 
In the National Registry of Myocardial Infarction, the in-
hospital death rate was 6.3% in 2006 (31). Older Puerto Rican 
patients were more likely to die while being hospitalized for 
AMI, which was also the case for female patients. A number of 
studies in populations composed primarily of white patients 
have shown advanced age to be an important factor in both 
the short- and long-term prognosis after AMI, and elderly 
individuals have been shown to be more likely to delay seeking 
timely medical treatment than are younger patients (41, 42). 
Other studies carried out in the U.S. have found that women 
also experienced higher rates of and earlier mortality than did 
men, which is similar to what has been seen in Puerto Rican 
women being hospitalized for AMI (32). Data from Olmsted 
County, Minnesota, suggest a poorer prognosis for women 
hospitalized with AMI than for men under like conditions. In 
that population-based study, the 28-day CFRs for the incident 
events of patients hospitalized with AMI were twofold higher for 
women than they were for men (29). Although the reasons for 
sex-based differences in the hospital death rates after AMI have 
not been fully elucidated, there is some concern that women 
might not be as rapidly and thoroughly managed as their male 
counterparts are and that men are more likely to complain of 
chest pain but less likely to present with nausea and neck, back, 
or jaw pain than women are (42).The continued monitoring of 
(4) Zevallos et al.indd   143 8/12/2013   8:43:51 AM
Acute Myocardial Infarction in Puerto Ricans: The Puerto Rico 
Heart Attack Study
144 PRHSJ Vol. 32 No. 3 • September, 2013
Zevallos et al
both in-hospital and long-term endpoints of both clinical and 
public relevance needs to take place as well as the identification 
of high-risk groups and the increased use of effective cardiac 
medications in these at-risk individuals.
Study strengths and limitations 
This community-based observational study has several 
strengths. The Puerto Rico Heart Attack Study is population-
based, includes unselected patients, and documents real-life 
management practices in the treatment of patients hospitalized 
with AMI. However, our data have several limitations that need 
to be taken into consideration when interpreting our study 
findings. We were unable to collect information on pre-hospital 
deaths; data were collected in a single calendar year and only 
included patients hospitalized with AMI and not those with 
other manifestations of underlying CHD. Lastly, we studied 
Puerto Rican patients only, and our findings may not be 
generalizable to other racial or ethnic groups. 
Conclusions
The findings of this study provide insights into the 
demographic and clinical profiles, therapeutic management, 
and in-hospital death rates of Puerto Rican men and women 
hospitalized with an initial AMI. At present, this is the only 
population-based study being conducted in Puerto Rico 
that describes the magnitude of AMI, its different clinical 
manifestations, the practices being utilized in its management, 
and in-hospital outcomes resulting from those practices. The 
design and implementation of population-based coronary 
disease surveillance studies is needed in order to obtain 
contemporary data that is necessary for the development of 
hospital and community-based planning measures for the 
more effective management, control, and prevention of AMI in 
these (i.e., Puerto Rican men and women) and other minority 
populations” or “in Hispanic and other minority populations.
Resumen
Objetivo: Existe información extremadamente limitada en 
poblaciones minoritarias, especialmente en hispanos, acerca 
de la epidemiología clínica de la enfermedad coronaria aguda. 
El objetivo de este estudio es examinar la incidencia de infarto 
agudo de miocardio (IAM), las tasas de mortalidad hospitalaria y 
el manejo terapéutico basado en evidencias en hispanos residentes 
en San Juan, Puerto Rico que fueron hospitalizados con un IAM 
inicial. Métodos: Personal del estudio debidamente entrenado 
obtuvo información de los récords médicos de pacientes 
hospitalizados con un posible IAM en doce hospitales localizados 
en San Juan durante el año calendario 2007. Resultados: La tasa 
de incidencia (# por 100,000 habitantes) de 1,415 pacientes 
hospitalizados con un diagnóstico independientemente validado 
de IAM aumentó con la edad y fue significativamente mayor 
en hombres (198) que en mujeres (134). El promedio de 
edad de la población bajo estudio fue de 64 años y 45% fueron 
mujeres. Las terapias cardiacas basadas en evidencia (aspirina, 
beta bloqueadores, inhibidores de la enzima convertora de la 
angiotensina/bloqueadores del receptor de la angiotensina 
y estatinas), se utilizaron en aproximadamente 60% de los 
pacientes hospitalizados. Las mujeres recibieron menos de estas 
terapias basadas en evidencia que los hombres (59% vs. 65%) y se 
sometieron a menos intervenciones coronarias percutáneas (47% 
vs. 59%) (p<0.05). La mortalidad hospitalaria se incrementó 
en pacientes de mayor edad y fue mayor en mujeres (8.6%) 
que en hombres (6.0%) (p<0.05). Conclusión: Es necesario 
disminuir la magnitud de IAM, aumentar el uso de terapias 
cardíacas basadas en evidencia, reducir las disparidades de género 
y mejorar el pronóstico de puertorriqueños hospitalizados con 
un IAM inicial. 
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